Microbot Medical Inc. (FRA:CY9D)

Market Cap	119.21M
Revenue (ttm)	n/a
Net Income (ttm)	-11.14M
Shares Out	n/a
EPS (ttm)	-0.33
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,000
Average Volume	484
Open	1.740
Previous Close	1.711
Day's Range	1.740 - 1.837
52-Week Range	0.919 - 4.268
Beta	n/a
RSI	46.69
Earnings Date	Mar 25, 2026

About Microbot Medical

Microbot Medical Inc. is a medical device company that focuses on transforming endovascular procedures through advanced robotic technology. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology i...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2010
• Employees: 20
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: CY9D

Financial Performance

Financial numbers in USD